Medicare’s Prescription Drug Plan Makeover

<p>An overhaul of Medicare’s prescription drug benefit will lower costs for seniors while changing incentives for insurers and drugmakers.</p><br><p>Guests</p><p>Therese Humphrey Ball, Multiple sclerosis patient and advocate.</p><p><a href="https://www.kff.org/person/juliette-cubanski/" rel="noopener noreferrer" target="_blank">Juliette Cubanski</a>, Deputy Director for Program on Medicare Policy at the Kaiser Family Foundation.</p><br><p>Learn more and read a full transcript on <a href="https://tradeoffs.org/2022/10/27/medicare-part-d-makeover" rel="noopener noreferrer" target="_blank">our website</a>.</p><br><p>Want more Tradeoffs? Sign up for our free <a href="https://tradeoffs.us3.list-manage.com/subscribe?u=6ab1fc39a0b1b15521551487c&amp;id=89c5edcb93&amp;utm_source=twitter-newsletter-signup&amp;utm_medium=twitter" rel="noopener noreferrer" target="_blank">weekly newsletter</a> featuring the latest health policy research and news.</p><br><p>Support this type of journalism today, <a href="https://tradeoffs.org/donate" rel="noopener noreferrer" target="_blank">with a gift</a>.</p><br /><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>